Trial Profile
A Phase I Study to Assess the Safety and Immunogenicity of Novel Routes of Administration of Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 and MVA Encoding ME-TRAP
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Malaria DNA vaccine (Primary) ; Malaria DNA vaccine (Primary)
- Indications Falciparum malaria; Malaria
- Focus Adverse reactions
- 19 Aug 2020 Status changed from recruiting to completed.
- 09 May 2019 Planned End Date changed from 1 Mar 2019 to 1 Dec 2019.
- 09 May 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Dec 2019.